Michael Mandel - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Michael Mandel

Showing results (11-20 of 13) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 13 results.

Journal of Crohn'S & Colitis|July 7, 2012

The risk of lymphoma and immunomodulators in patients with inflammatory bowel diseases: results from a population-based cohort in Eastern EuropePeter L Lakatos, Barbara D Lovasz, Gyula David, et al.

Inflammatory Bowel Diseases|February 13, 2013

Is current smoking still an important environmental factor in inflammatory bowel diseases? Results from a population-based incident cohortPeter L Lakatos, Zsuzsanna Vegh, Barbara D Lovasz, et al.

American Journal of Respiratory and Critical Care Medicine|February 10, 2007

The safety and efficacy of infliximab in moderate to severe chronic obstructive pulmonary diseaseStephen I Rennard, Charles Fogarty, Steven Kelsen, et al.

Pageof 2

Search research articles

Showing results (11-20 of 13) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 13 results.

Journal of Crohn'S & Colitis|July 7, 2012

The risk of lymphoma and immunomodulators in patients with inflammatory bowel diseases: results from a population-based cohort in Eastern EuropePeter L Lakatos, Barbara D Lovasz, Gyula David, et al.

Inflammatory Bowel Diseases|February 13, 2013

Is current smoking still an important environmental factor in inflammatory bowel diseases? Results from a population-based incident cohortPeter L Lakatos, Zsuzsanna Vegh, Barbara D Lovasz, et al.

American Journal of Respiratory and Critical Care Medicine|February 10, 2007

The safety and efficacy of infliximab in moderate to severe chronic obstructive pulmonary diseaseStephen I Rennard, Charles Fogarty, Steven Kelsen, et al.

Pageof 2